10 Most-Advertised Brand-Name Drugs

AUGUST 27, 2015
Allison Gilchrist, Associate Editor


7.      Xeljanz ($160.7 million spent on advertising)

Pfizer targeted its advertising for Xeljanz as a rheumatoid arthritis (RA) treatment.
 
Earlier this year, the FDA accepted to review Xeljanz as a potential treatment for adult psoriasis. It is also reviewing a once-daily formulation of Xeljanz for RA.


SHARE THIS
1